Precision Medicine Platforms
Part of Healthcare - Genomics & Precision Medicine
 AZN | AstraZeneca PLC | $263.1b | $160.99 | +0.2% | 574.2K |
 TMO | Thermo Fisher Scientific, Inc. | $212.2b | $585.55 | +0.6% | 280.7K |
 DHR | Danaher Corporation | $137.1b | $202.59 | +1.0% | 528.6K |
 WAT | Waters Corp | $36.8b | $399.42 | +0.2% | 73.4K |
 GH | Guardant Health, Inc. Common Stock | $21.7b | $165.95 | +5.7% | 515.9K |
 BBIO | BridgeBio Pharma, Inc. Common Stock | $15.7b | $83.14 | +0.7% | 158.2K |
 RVTY | Revvity, Inc. | $12.9b | $115.38 | +0.6% | 92.9K |
 TECH | Bio-Techne Corp. | $11.2b | $72.26 | +0.4% | 557.3K |
 NUVL | Nuvalent, Inc. Class A Common Stock | $9.8b | $123.96 | 0.0% | N/A |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | $8.5b | $358.48 | -2.2% | 120.9K |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $8.5b | $105.14 | -1.2% | 91.5K |
 TEM | Tempus AI, Inc. Class A Common Stock | $8.3b | $49.88 | +7.7% | 1.5M |
 LNTH | Lantheus Holdings, Inc | $6.5b | $101.08 | +0.1% | 263.9K |
 TWST | Twist Bioscience Corporation Common Stock | $6.3b | $113.54 | +5.1% | 262.3K |
 DYN | Dyne Therapeutics, Inc. Common Stock | $4.7b | $25.66 | -0.4% | 286.1K |
 CAI | Caris Life Sciences, Inc. Common Stock | $4.4b | $21.31 | +5.8% | 1.3M |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | $3.6b | $24.42 | +3.8% | 550.9K |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | $3.4b | $36.51 | +1.1% | 99.1K |
 CDNA | CareDx, Inc. | $2.3b | $45.62 | +2.1% | 156.5K |
 WGS | GeneDx Holdings Corp. Class A Common Stock | $2.0b | $73.42 | +7.0% | 229.8K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.5b | $27.99 | -2.1% | 56.9K |
 ANRO | Alto Neuroscience Inc. | $1.1b | $28.20 | -0.3% | 57.2K |
 CSTL | Castle Biosciences, Inc. Common Stock | $0.9b | $31.54 | +3.4% | 22.0K |
 AURA | Aura Biosciences, Inc. Common Stock | $0.7b | $7.83 | +1.4% | 65.2K |
 NVCT | Nuvectis Pharma, Inc. Common Stock | $0.7b | $18.84 | +1.0% | 28.0K |
 CTKB | Cytek Biosciences, Inc. Common Stock | $0.5b | $4.17 | -0.1% | 74.0K |
 SOPH | SOPHiA GENETICS SA Ordinary Shares | $477.4m | $6.81 | +1.3% | 61.7K |
 PRLD | Prelude Therapeutics Incorporated | $349.6m | $4.65 | +0.2% | 16.7K |
 LAB | Standard BioTools Inc. Common Stock | $339.8m | $0.81 | -0.0% | 45.2K |
 OABI | OmniAb, Inc. Common Stock | $284.1m | $2.77 | +20.8% | 496.9K |
 FHTX | Foghorn Therapeutics Inc. Common Stock | $266.0m | $5.79 | +3.4% | 50.9K |
 AVXL | Anavex Life Sciences | $254.8m | $3.38 | +2.7% | 147.8K |
 ACIU | AC Immune SA | $222.9m | $2.31 | +0.2% | 13.5K |
 BDSX | Biodesix, Inc. Common Stock | $219.5m | $22.98 | +4.7% | 13.2K |
 QTRX | Quanterix Corporation Common Stock | $174.8m | $4.00 | +4.2% | 119.5K |
 QSI | Quantum-Si Incorporated Class A Common Stock | $162.4m | $0.81 | +4.6% | 690.8K |
 NAUT | Nautilus Biotechnolgy, Inc. Common Stock | $128.5m | $0.88 | -1.9% | 172.3K |
 SEER | Seer, Inc. Class A Common Stock | $123.2m | $2.19 | +0.2% | 18.2K |
 XGN | Exagen Inc. Common Stock | $113.1m | $6.66 | +1.4% | 98.6K |
 SERA | Sera Prognostics, Inc. Class A Common Stock | $82.2m | $1.85 | 0.0% | 2.0K |
 CSBR | Champions Oncology, Inc. | $74.5m | $5.21 | 0.0% | 244 |
 IBIO | iBio, Inc. Common Stock | $69.5m | $1.38 | +0.4% | 83.2K |
 ACRV | Acrivon Therapeutics, Inc. Common Stock | $64.2m | $1.75 | +1.8% | 113.2K |
 TVGN | Tevogen Inc. Common Stock | $29.6m | $6.52 | 0.0% | 921 |
 CCEL | Cryo-Cell International Inc. | $27.6m | $3.67 | -2.5% | 388 |
 MDXH | MDxHealth SA Ordinary Shares | $23.4m | $0.44 | -2.6% | 236.2K |
 ALLR | Allarity Therapeutics, Inc. Common Stock | $19.3m | $1.37 | -0.7% | 19.7K |
 ADVB | Advanced Biomed Inc. Common Stock | $13.2m | $7.41 | -0.7% | 22.1K |
 CDIO | Cardio Diagnostics Holdings Inc. Common stock | $4.6m | $1.74 | +0.6% | 3.6K |